Skip to main content
Premium Trial:

Request an Annual Quote

Geospiza, NuGen to Co-market Next-gen Sequencing Workflow Products

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Geospiza announced today a co-marketing deal with NuGen Technologies for the development of a next-generation sequencing workflow to accelerate discoveries for large disease research studies.

Financial and other terms of the deal were not disclosed.

Based in Seattle, Geospiza develops software for genetic analysis. NuGen, based in San Carlos, Calif., develops amplification and labeling systems for genomic research.

A spokeswoman for NuGen told GenomeWeb Daily News that the company will be providing library sample preparation technology to the collaboration.

"Combining our GeneSifter preconfigured lab and analysis cloud software with NuGen's Ovation and Encore reagents enables researchers to follow and document a step-by-step best practice for sample preparation combined with fully integrated data analysis and other sample information in one system," Rob Arnold, president of Geospiza, said in a statement.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.